Jounce Therapeutics, Inc.
(NASDAQ : JNCE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.43%179.121.2%$610.49m
CELGCelgene Corporation
1.24%77.561.2%$572.29m
GILDGilead Sciences, Inc.
0.32%68.050.9%$552.74m
BIIBBiogen Inc.
1.33%283.411.2%$527.56m
REGNRegeneron Pharmaceuticals, Inc.
0.00%294.692.6%$308.55m
ILMNIllumina, Inc.
0.14%271.193.5%$235.70m
VRTXVertex Pharmaceuticals Incorporated
-0.04%156.221.9%$230.33m
ALXNAlexion Pharmaceuticals, Inc.
-0.86%117.992.0%$223.00m
AAgilent Technologies, Inc.
-0.58%64.471.5%$209.55m
NKTRNektar Therapeutics
0.07%82.016.0%$198.45m
INCYIncyte Corporation
0.15%66.662.5%$176.90m
SRPTSarepta Therapeutics, Inc.
-0.91%88.4116.6%$123.87m
BMRNBioMarin Pharmaceutical Inc.
2.02%89.384.4%$119.70m
EXASExact Sciences Corporation
-3.54%51.1225.5%$111.98m
BLUEBluebird Bio, Inc.
1.45%188.3515.7%$96.10m

Company Profile

Jounce Therapeutics, Inc. develops and manufactures drugs and immunotherapies. It produces cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber and Padmanee Sharmain in 2013 and is headquartered in Cambridge, MA.